Literature DB >> 9524100

5-Fluorocytosine-mediated apoptosis and DNA damage in glioma cells engineered to express cytosine deaminase and their enhancement with interferon.

Z H Wang1, S Samuels, M A Gama Sosa, E H Kolodny.   

Abstract

To explore the antitumor mechanism of bacterial cytosine deaminase plus 5-fluorocytosine (CD/5-FCyt) in combination with interferons (IFNs), glioma cells were transduced with recombinant retroviruses expressing CD. The transduced glioma cells become sensitive to the nontoxic prodrug 5-FCyt. Apoptosis, DNA damage, bystander effect, and inhibition of thymidylate synthase (TS) and DNA synthesis are associated with CD/5-FCyt-mediated glioma cell killing. Furthermore, IFNs enhance this effect by increasing DNA damage and further inhibiting TS activity. The bystander effect is mediated by the release of cytotoxic metabolites of 5-FCyt into the extracellular milieu triggering apoptosis and DNA damage. Our data indicate that the use of CD/5-FCyt in combination with IFNs may provide a more effective approach for the treatment of brain tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9524100     DOI: 10.1023/a:1005883128175

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Regulation of insulin-like growth factor I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor.

Authors:  W L Lowe; T Meyer; C W Karpen; L R Lorentzen
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

Review 2.  Gene therapy for brain tumors.

Authors:  C M Kramm; M Sena-Esteves; F H Barnett; N G Rainov; D E Schuback; J S Yu; P A Pechan; W Paulus; E A Chiocca; X O Breakefield
Journal:  Brain Pathol       Date:  1995-10       Impact factor: 6.508

Review 3.  Biochemical modulation of cytotoxic drugs by cytokines: molecular mechanisms in experimental oncology.

Authors:  E D Kreuser; S Wadler; E Thiel
Journal:  Recent Results Cancer Res       Date:  1995

4.  An experimental model of retrovirus gene therapy for malignant brain tumors.

Authors:  Y Takamiya; M P Short; F L Moolten; C Fleet; T Mineta; X O Breakefield; R L Martuza
Journal:  J Neurosurg       Date:  1993-07       Impact factor: 5.115

5.  Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro.

Authors:  J C Yalowich; T I Kalman
Journal:  Biochem Pharmacol       Date:  1985-07-01       Impact factor: 5.858

6.  Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

Authors:  B E Huber; E A Austin; C A Richards; S T Davis; S S Good
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

7.  In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.

Authors:  Z Ram; K W Culver; S Walbridge; R M Blaese; E H Oldfield
Journal:  Cancer Res       Date:  1993-01-01       Impact factor: 12.701

8.  Gene therapy for cancer using tumour-specific prodrug activation.

Authors:  J D Harris; A A Gutierrez; H C Hurst; K Sikora; N R Lemoine
Journal:  Gene Ther       Date:  1994-05       Impact factor: 5.250

Review 9.  Gene transfer technologies for the gene therapy of cancer.

Authors:  R Vile; S J Russell
Journal:  Gene Ther       Date:  1994-03       Impact factor: 5.250

10.  Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.

Authors:  C A Mullen; M M Coale; R Lowe; R M Blaese
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

View more
  2 in total

Review 1.  Prodrug approaches for CNS delivery.

Authors:  Jarkko Rautio; Krista Laine; Mikko Gynther; Jouko Savolainen
Journal:  AAPS J       Date:  2008-02-05       Impact factor: 4.009

Review 2.  Mitochondrial determinants of cancer health disparities.

Authors:  Aaheli Roy Choudhury; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-06       Impact factor: 15.707

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.